EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Average Recommendation of “Moderate Buy” from Analysts

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) has earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have issued a buy recommendation and two have issued a strong buy recommendation on the company.

Several analysts recently weighed in on ESLOY shares. The Goldman Sachs Group cut shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. Finally, Zacks Research lowered shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd.

EssilorLuxottica Price Performance

ESLOY opened at $92.54 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70. The stock’s 50 day moving average price is $98.99 and its 200-day moving average price is $119.42. EssilorLuxottica has a 52-week low of $91.44 and a 52-week high of $186.81.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.